Life Science Case Interview: Format, GlobaPharm Walkthrough, and Out-Loud Practice

A life science case interview evaluates how you structure complex problems, analyze data, and communicate reasoning on business scenarios such as McKinsey's official GlobaPharm practice case, where a $10 billion pharmaceutical company considers buying a $1 billion biologicals start-up. Firms like McKinsey and BCG state that there is no single right answer and advise sharing tailored solutions rather than standard frameworks while working through calculations on paper without a calculator. You can rehearse these skills right now by speaking through the four GlobaPharm prompts out loud.

Updated

What a life science case interview tests

During a Problem-Solving Interview at McKinsey or a case study interview at BCG, your interviewer presents a realistic client scenario to evaluate how you approach complex problems. Both firms state that there is not always a single logical or right answer. Interviewers look at how you structure your approach, ask thoughtful questions, analyze data, perform quick calculations on paper, and communicate your reasoning.

Life science cases apply these exact steps to pharmaceutical and biotechnology decisions. In McKinsey's published GlobaPharm practice case, you evaluate whether a traditional small-molecule pharmaceutical company should acquire a biologicals start-up, assess the value of a clinical drug pipeline, calculate the Phase II success rate increase needed to break even on a trial investment, and identify the risks of merging two research and development organizations.

You do not need to memorize rigid templates before your round. McKinsey advises candidates to listen carefully and share tailored solutions rather than standard frameworks. When you are ready to test your spoken timing, you can practice a case free, no sign-up, and hear how your structure sounds out loud.

How the interview rounds work at McKinsey and BCG

Your case round sits inside a broader evaluation process. At McKinsey, most consulting roles begin with Solve, a gamified assessment that tests your natural problem-solving abilities, and technical roles may include a hands-on technical assessment covering programming, data analysis, or system design. For most client-facing roles at McKinsey, your live rounds combine Personal Experience Interviews (PEI) with Problem-Solving Interviews, and some roles add an Expertise Interview to test how your specific experience and skill set fit the position.

In the McKinsey Personal Experience Interview, you discuss important past accomplishments and challenges in detail. McKinsey recommends preparing two personal examples for each of its four PEI themes, focusing on your specific role and leading with your reasoning rather than just listing actions.

BCG organizes its consulting interview process as a two-way conversation across four steps: Step 1 is the online application, Step 2 is a traditional Skills Interview exploring your experience and motivation beyond your resume, Step 3 is the Case Interview for client-facing roles, and Step 4 is the Team Interview assessing your problem-solving, analytical, and communication skills. BCG also offers OneDay@BCG, a free job simulation that shows the types of challenges its consultants solve.

Published interview steps and preparation rules at McKinsey and BCG

Published interview steps and preparation rules at McKinsey and BCG
Stage or RuleMcKinsey Official ProcessBCG Official Process
Early AssessmentSolve gamified assessment for most consulting roles. Hands-on technical assessment for technical roles.Step 1 Application in portal. Free OneDay@BCG job simulation available for practice.
Experience & FitPersonal Experience Interview (PEI). Prepare 2 examples per theme, focus on your specific role, and lead with reasoning.Step 2 Skills Interview. Traditional interview exploring experience, skills, and motivation beyond your resume.
Case & Team RoundsProblem-Solving Interview using a typical client scenario, plus an Expertise Interview for certain roles.Step 3 Case Interview and Step 4 Team Interview for client-facing roles.
Core Case GuidanceShare tailored solutions vs. standard frameworks. Calculators are not allowed, write calculations on paper.Work step-by-step: structure approach, ask questions, analyze data, do quick calculations, and show your thinking.

Reasoning and communication steps from the firms' prep pages

McKinsey and BCG publish clear instructions on what to do and what to avoid during your case conversation. Every step rewards organized thinking spoken out loud over silent speed.

Follow this seven-step checklist built directly from McKinsey and BCG's official preparation guidance:

  • Listen actively and take notes: Write down the important information and numbers from the prompt as the interviewer speaks.
  • Clarify unclear points and assumptions: If a question or term is not clear, speak up and ask the interviewer to repeat or explain it.
  • Pause to organize your thoughts: Take time before answering to develop an overall approach before diving into specific details. Avoid rushing your response or panicking under pressure.
  • Build a tailored structure, not a standard framework: Group your thoughts around the specific client problem and avoid overcomplicating solutions.
  • Breadth first, then check in: When exploring an area like a drug portfolio, mention a broad range of potential issues first instead of diving deep into one single point, then ask your interviewer where they want to go deeper.
  • Plan and narrate paper math: Calculators are not allowed in McKinsey interviews. Write your calculations on paper, take time to plan your approach, and talk your interviewer through each step out loud rather than staying silent.
  • Adapt to feedback without interrupting: Treat the interview as a two-way conversation, listen to cues from your interviewer, and never ignore feedback or interrupt.

Rehearse out loud: McKinsey's GlobaPharm practice case

The best way to prepare for a life science case interview is to work through an official pharmaceutical scenario out loud. McKinsey publishes the GlobaPharm practice case on its careers site to show the exact types of questions asked in a Problem-Solving Interview.

Read the official scenario below, grab a pen and paper, and speak your answers to the four questions out loud before checking how we structure them.

The client scenario: GlobaPharm is a major pharmaceutical company headquartered in Germany with primary research and development (R&D) centers in Germany, regional sales offices worldwide, and $10 billion a year in revenue. GlobaPharm has a long tradition in small-molecule drugs, such as aspirin and most blood-pressure or cholesterol medications. Now it wants to enter biologicals, a rapidly growing segment of proteins or large, complex molecules that treat conditions traditional drugs cannot address.

Biologicals R&D is vastly different from small-molecule R&D. Pharmaceutical companies can gain these capabilities in three ways: build them from scratch, partner with existing start-ups, or acquire the start-ups. Because competitors are already several years ahead, GlobaPharm wants to jumpstart its biologicals program by acquiring BioFuture, a publicly traded biologicals start-up in the San Francisco area founded 12 years ago by prominent scientists. BioFuture employs 200 people and is worth about $1 billion at its current share price. The overall question is: Should GlobaPharm acquire BioFuture?

  • Question 1 (Acquisition & Strategic Fit): What factors should the team consider when evaluating whether GlobaPharm should acquire BioFuture? Hint: Take time to organize your thoughts and develop an overall approach before diving into details. Practice saying three to four tailored buckets out loud, such as the value of BioFuture's current pipeline and R&D platform, how acquiring compares to building from scratch or partnering, whether the $1 billion price plus premium is justified, and whether a German small-molecule firm can integrate a 200-person San Francisco biotech team.
  • Question 2 (Drug Pipeline Valuation): The team decides to focus first on evaluating the value of BioFuture's current drug portfolio. What issues should the team consider when evaluating the value of BioFuture's existing drug pipeline? Hint: Mention a range of potential issues first instead of diving deep into one, then ask your interviewer if they want to go deeper on any specific area. Speak across the clinical stages and probabilities of success, the patient market size and pricing potential for each candidate drug, the remaining trial and filing costs, and the competitive biologicals landscape.
  • Question 3 (Phase II Break-Even Calculation): Below is a description of expected probability of success by stage in the Pharma R&D pipeline, where Filing means submitting all clinical and safety evidence from Phase I, II, and III trials to request regulatory approval to sell the drug. GlobaPharm believes the likelihood of success of BioFuture's primary drug candidate can be improved by investing an additional $150 million in a larger Phase II trial, raising the Phase II success rate so more candidate drugs make it to Phase III and beyond. Assuming a successfully marketed and sold drug has a present value of $1.2 billion in future profits, by how much would the Phase II success rate need to increase for this $150 million investment to break even?
  • Question 4 (Post-Merger R&D Integration Risks): Although BioFuture's existing drug pipeline is relatively limited, GlobaPharm is highly interested in its ability to serve as a biological research engine that, combined with GlobaPharm's existing R&D assets, will produce many candidate drugs over the next 10 years. What are your hypotheses on the major risks of integrating the R&D functions of BioFuture and GlobaPharm? Group your hypotheses logically: retaining the prominent scientists and 200 employees in San Francisco, bridging cultural and process differences between a 12-year-old California start-up and a major German headquarters, and linking biological discovery with GlobaPharm's clinical trial and global sales infrastructure.

Worked example: solving the GlobaPharm Phase II break-even math on paper

Question 3 of McKinsey's GlobaPharm case tests how you plan a probability calculation on paper and explain every step out loud without a calculator. McKinsey's public web page gives the $150 million Phase II investment and the $1.2 billion present value of a marketed drug, while the stage-by-stage transition chart is held inside the interview prompt.

Here is how you set up the exact break-even equation from McKinsey's official numbers, followed by a complete worked calculation using illustrative downstream probabilities labeled as our example so you can rehearse the arithmetic.

Step 1: Compare the investment to the final reward. By our calculation from McKinsey's GlobaPharm figures, dividing the $150 million additional Phase II investment by the $1.2 billion present value of a successfully marketed drug gives 0.125, or 12.5%. That means the $150 million investment breaks even if the overall probability of the drug reaching the market and being sold increases by 12.5 percentage points (assuming downstream trial costs are already netted into the $1.2 billion present value or held constant).

Step 2: Account for Phase III and Filing success rates. Passing Phase II does not guarantee a marketed drug. The candidate must still pass Phase III and regulatory Filing. If we call the increase in Phase II success rate Delta P2, then Delta P2 multiplied by the Phase III success rate and the Filing success rate must equal 12.5 percentage points.

Step 3: Work an illustrative numerical example out loud (our invented stage probabilities for practice). Suppose the interviewer's chart shows that a drug entering Phase III has a 50% chance of passing Phase III and an 80% chance of passing regulatory Filing. Multiply 50% by 80% on paper to get a 40% combined chance that a drug finishing Phase II eventually reaches the market. Now divide the required 12.5 percentage point overall gain by 0.40: 12.5% divided by 0.40 equals 31.25 percentage points. You would tell the interviewer that the Phase II success rate must increase by 31.25 percentage points for the $150 million investment to break even.

Advanced Professional Degree (APD) pathways, eligibility, and 2026 deadlines

If you are searching for life science case interviews while completing a graduate or medical degree, McKinsey has a dedicated recruiting pathway for you. McKinsey states that it seeks problem-solvers from a wide range of disciplines, including medicine, engineering, law, military service, and professional sports.

At McKinsey, the Advanced Professional Degree (APD) group represents candidates who are postdocs or working toward a PhD, MD (including medical interns, residents, and fellows), JD, PharmD, Nursing degree, or non-MBA Masters degree. APD candidates typically join McKinsey as full-time Associates and can work either as generalists or as expert consultants focused on a specific industry or function such as digital, analytics, or operations.

If you hold a non-MBA Masters degree, McKinsey requires at least four years between the completion of your undergraduate degree and your graduate degree to qualify as an APD Associate candidate. Non-MBA Masters candidates with less than four years between their undergraduate and graduate degrees qualify for the Business Analyst position instead. APD candidates can also apply to technical and non-consulting roles such as data scientists, software engineers, product managers, data engineers, and designers.

McKinsey publishes specific application windows for the 2026 and 2027 APD Associate cohorts, plus its Connect with APD 2026 program, which provides resume workshops, recruiter check-ins, affinity network connections, and priority access to the Solve assessment game.

McKinsey Advanced Professional Degree (APD) Associate deadlines and eligibility

McKinsey Advanced Professional Degree (APD) Associate deadlines and eligibility
Graduation WindowApplication DeadlineReview Process & Notes
Graduated or graduating by October 2026 (before November 2026)June 26, 2026Class of 2026 Associate cohort. Reviewed on a rolling basis. Applicants must be able to start in the role this calendar year.
Graduating between December 2026 and Fall 2027August 11, 2026 (apply July 1 to August 11, 2026)Full-time Associate applications are processed after the August 11, 2026 deadline. Eligible for Connect with APD 2026.
Graduating after Fall 2027In 2027Can register early through Connect with APD 2026 to join events, newsletters, and recruiting activities.
Using AI in preparation and setting up your virtual interview

McKinsey explicitly encourages candidates to use AI responsibly during interview preparation, comparing it to seeking feedback from mentors, friends, or family. On its official interviewing page, McKinsey lists three encouraged uses of AI: polishing your resume, practicing interview questions, and asking AI to explain concepts or frameworks as part of your prep.

At the same time, McKinsey strictly forbids exaggerating or creating achievements that are not yours, generating real-time answers during an interview, or using AI during assessments unless specifically permitted.

When you sit for a virtual interview, McKinsey recommends a specific room and computer setup so your session matches an in-person meeting without violating assessment integrity rules:

  • Choose a quiet, private space and use headphones to minimize background noise.
  • Keep your laptop charger, pen, paper, and water within reach.
  • Disable any previously installed AI software, such as note-taking tools or virtual assistants, so they do not unintentionally record or assist with the interview.
  • Keep your camera turned on and run a video check ahead of time to confirm your camera angle and make sure all virtual backgrounds or blurring features are disabled.

How to practice life science cases out loud this week

Reading sample prompts silently will not build the habit of organizing your thoughts on paper and talking an interviewer through your math. Set aside time each day to speak your structures, pipeline lists, and paper calculations out loud.

You can rehearse the GlobaPharm prompts above with a timer, check our consulting case study examples for more practice prompts across industries, or review the McKinsey case interview and BCG case interview format guides. When you are ready for live follow-up questions on your structure and math, practice a case free, no sign-up, with Soreno's AI interviewer.

From McKinsey & Company: Interviewing at McKinsey, McKinsey & Company: GlobaPharm Practice Case, McKinsey & Company: Tips for Advanced Professional Degree Candidates, BCG Careers: Consulting Case Study Interview Preparation and BCG Careers: Consulting Interview Process.

1 practice question and sample answer

Say your answer out loud first, then read the sample answer.

Practice question

  1. McKinsey GlobaPharm Practice Case, Question 2: The team wants to explore BioFuture's current drug pipeline and decides to focus first on evaluating the value of BioFuture's current drug portfolio. What issues should the team consider when evaluating the value of BioFuture's existing drug pipeline?

    Sample answer. Example answer written by our team. The applicant is invented. "To evaluate the value of BioFuture's existing biologicals pipeline, I would group the issues we need to investigate into four areas: clinical development status, commercial revenue potential, remaining investment and operating costs, and external competitive or regulatory risks. First, on clinical status, we should look at how many drug candidates BioFuture has across Phase I, Phase II, Phase III, and Filing, and the expected probability of success at each stage. Second, on commercial potential, for each candidate that reaches the market, we need to examine the medical condition it treats, the addressable patient population, how effective the biological is compared to existing treatments, and the price and sales volume GlobaPharm could achieve through its global sales offices. Third, on costs, we should account for the remaining clinical trial expenses, regulatory filing costs, and biological manufacturing costs required to bring those drugs to market. Fourth, on external risks, we should check patent protection timelines and whether competing pharma companies are developing similar biological molecules. Would you like me to go deeper into any one of those four areas first?"

    Follows McKinsey's exact hint for Question 2: organizes thoughts into a clear high-level approach, mentions a broad range of pipeline issues across clinical probability, commercial value, trial and filing costs, and competition without getting stuck in a single detail, and ends by asking the interviewer where to go deeper.

Practice the case interview, out loud

Soreno's AI interviewer runs a full case one question at a time, checks your math and scores your structure, any time you have 30 minutes.

Questions people ask

Do I need a medical or PhD background for a life science case interview?

No. McKinsey states that it seeks problem-solvers from a wide range of disciplines, whether you come from medicine, law, engineering, military service, professional sports, or another field, while also offering a dedicated Advanced Professional Degree (APD) path for PhD, MD, PharmD, Nursing, and qualifying non-MBA Masters candidates.

Are calculators or standard frameworks allowed in a pharma case interview?

In McKinsey's GlobaPharm practice case and interviewing guide, calculators are not allowed, so you write out calculations on paper and talk the interviewer through your steps. Both McKinsey and BCG advise sharing tailored, logical approaches rather than relying on standard frameworks because there is not a single right answer.

What is McKinsey's GlobaPharm practice case about?

GlobaPharm is an official McKinsey practice case about a German pharmaceutical company with $10 billion in annual revenue from small-molecule drugs that wants to enter the biologicals segment by acquiring BioFuture, a 200-person San Francisco start-up valued at $1 billion. Candidates evaluate strategic acquisition factors, BioFuture's drug pipeline value, a $150 million Phase II clinical trial break-even calculation, and 10-year R&D integration risks.

Can I use AI tools to prepare for a consulting case interview?

Yes, during preparation only. McKinsey encourages using AI to practice interview questions, polish your resume, and explain concepts or frameworks during prep, but forbids using AI during assessments or to generate real-time answers during an interview, and asks you to disable AI note-takers and virtual assistants before virtual interviews.

How do non-MBA Masters candidates qualify for McKinsey's APD Associate role?

McKinsey states that non-MBA Masters candidates must have at least four years between finishing their undergraduate degree and completing their graduate degree to qualify as an Advanced Professional Degree (APD) Associate candidate. Those with fewer than four years between degrees qualify for the Business Analyst role.

Keep going